2007-May Archives by Author

• Messages sorted by: [ thread ] [ subject ] [ date ]
• More info on this list...

Starting: Tue May 1 05:50:09 2007
Ending: Thu May 31 04:25:27 2007
Messages: 242

• [Ip-health] Brazil Bypasses Patent on U.S. AIDS Drug   =?ISO-8859-1?Q?Ga=EBlle_Krikorian?=
• [Ip-health] obviousness: KSR International v. Teleflex   =?ISO-8859-1?Q?Ga=EBlle_Krikorian?=
• [Ip-health] Venezuela: Antitrust Authorities Sentenced Against Exclusionary Practices Between Pharmaceutical Companies   =?ISO-8859-1?Q?Ga=EBlle_Krikorian?=
• [Ip-health] geneva event on patents and access to medicine in africa   =?ISO-8859-1?Q?Mar=EDa_Julia_Oliva?=
• [Ip-health] Worldwide student competition brings WTO debate battle to Geneva   =?iso-8859-1?Q?Maria_Moguilnaia_/_EMC=B2_Public_Relations?=
• [Ip-health] Le Monde on WHA: Indonesia and H5N1 samples   James ARKINSTALL
• [Ip-health] FT: Boerhinger Ingelheim to slash price of nevirapine   James ARKINSTALL
• [Ip-health] US government trying to seize new Michael Moore film, says producer   Tahir Amin
• [Ip-health] Pfizer v. Apotex (IP Frontline)   Tahir Amin
• [Ip-health] (no subject)   B.Baker@neu.edu
• [Ip-health] US Action Plan for Thailand comes straight from Pharma   B.Baker@neu.edu
• [Ip-health] Bangkok Post, Thailand considers revoking C.L. on Merck's efavirenz   B.Baker@neu.edu
• [Ip-health] Wall Street Journal: Patent Holders' Grip Weakens   Thiru Balasubramaniam
• [Ip-health] The Associated Press: Thailand to talk with U.S. about drug patents after being targeted for copyright violations   Thiru Balasubramaniam
• [Ip-health] Wall Street Journal editorial: Abbott's Bad Precedent   Thiru Balasubramaniam
• [Ip-health] Chicago Tribune: Thailand scolded over not honoring patents   Thiru Balasubramaniam
• [Ip-health] Wall Street Journal editorial: Patently Obvious   Thiru Balasubramaniam
• [Ip-health] AFP: Thais protest against US copyright report amid drugs row   Thiru Balasubramaniam
• [Ip-health] IP-Watch: US Investigators In Geneva To Review US Balance On IP, Public Health   Thiru Balasubramaniam
• [Ip-health] Bloomberg: Brazil to Break Patent on Merck's Efavirenz AIDS Drug   Thiru Balasubramaniam
• [Ip-health] AP: Brazil AIDS Drug Negotiations Break Down   Thiru Balasubramaniam
• [Ip-health] Economist: Patently obvious   Thiru Balasubramaniam
• [Ip-health] =?WINDOWS-1252?Q?Jacob_Golstein's_Health_Blog_in_the_Wall_Street?= =?WINDOWS-1252?Q?_Journal:_Brazil_Breaks_Merck=92s_Patent_on_AID?= =?WINDOWS-1252?Q?S_Drug?=   Thiru Balasubramaniam
• [Ip-health] Wall Street Journal: Brazil to Break Patent On Merck AIDS Drug   Thiru Balasubramaniam
• [Ip-health] Financial Times: Brazil spurns patent on HIV drug   Thiru Balasubramaniam
• [Ip-health] Folha de Sao Paolo: Ministro da Saude contesta ataques a quebra de patente   Thiru Balasubramaniam
• [Ip-health] BBC: Brazil to break Aids drug patent   Thiru Balasubramaniam
• [Ip-health] IP-Watch: Brazil Takes Steps To Import Cheaper AIDS Drug Under Trade Law   Thiru Balasubramaniam
• [Ip-health] O Estado de Sao Paulo: Governo dos EUA lamenta decisao   Thiru Balasubramaniam
• [Ip-health] New Yorker: Exporting I.P.   Thiru Balasubramaniam
• [Ip-health] Associated Press: Clinton, Drug Companies Strike Deal to Lower AIDS Drug Prices   Thiru Balasubramaniam
• [Ip-health] Reuters piece on Clinton supporting Thai and Brazilian CL decisions   Thiru Balasubramaniam
• [Ip-health] Bridges Weekly: BRAZIL ISSUES COMPULSORY LICENCE FOR AIDS DRUG   Thiru Balasubramaniam
• [Ip-health] IP-Watch: IP Issues May Spark Debate At World Health Assembly   Thiru Balasubramaniam
• [Ip-health] Wall Street Journal: Bush, Congress Agree On Trade Standards   Thiru Balasubramaniam
• [Ip-health] WHO technical briefing: Technical briefing: Public Health, Innovation and Intellectual property   Thiru Balasubramaniam
• [Ip-health] Inter Press Service News Agency: Thailand Turns Giant Pharma Killer   Thiru Balasubramaniam
• [Ip-health] Christian Medical Commission (CMC) Briefing at WHA (May 18) on Innovation and Access in the Context of WHO IGWG   Thiru Balasubramaniam
• [Ip-health] Letter to the Editor (Wall Street Journal): Thailand's Compulsory Drug Licensing   Thiru Balasubramaniam
• [Ip-health] Financial Times: Indonesia lifts bird flu sample ban   Thiru Balasubramaniam
• [Ip-health] IP-Watch: Health Assembly Tackles Proposals On Avian Flu Virus Sharing   Thiru Balasubramaniam
• [Ip-health] Financial Times: Patent revolution   Thiru Balasubramaniam
• [Ip-health] Extract of Statement by German Presidency (for EU) at WHA: "Draft medium-term strategic plan 2008-2013"   Thiru Balasubramaniam
• [Ip-health] Wall Street Journal: In Trade Deal, a Shift on Generics   Thiru Balasubramaniam
• [Ip-health] AP: Chan: Bird Flu Huge Global Health Threat   Thiru Balasubramaniam
• [Ip-health] IP-Watch: IP Rises At Assembly As Brazil Proposes Greater WHO Role In Trade   Thiru Balasubramaniam
• [Ip-health] WHA discussions this afternoon   Thiru Balasubramaniam
• [Ip-health] Christian Medical Commission statement at World Health Assembly   Thiru Balasubramaniam
• [Ip-health] WHO public health, innovation and intellectual property discussions   Thiru Balasubramaniam
• [Ip-health] WHO drafting group on Brazilian resolution at 6 PM today   Thiru Balasubramaniam
• [Ip-health] Projected financial implications for adopting Brazilian resolution (prepared by Secretariat)   Thiru Balasubramaniam
• [Ip-health] IP-Watch: WHO Members Reach Preliminary Agreement On TRIPS And Malaria   Thiru Balasubramaniam
• [Ip-health] Thai News Agency: Thailand, Brazil to sign health cooperation agreement   Thiru Balasubramaniam
• [Ip-health] IP-Watch: Health Assembly Sets Up Drafting Group On Brazil IP Proposal   Thiru Balasubramaniam
• [Ip-health] Reuters: Thailand Fails to Win Over U.S. on Drug Patents   Thiru Balasubramaniam
• [Ip-health] WHO press release: Agreement reached on influenza virus sharing, intellectual property   Thiru Balasubramaniam
• [Ip-health] KEI statement on adoption of WHO resolution "Public health, innovation and intellectual property"   Thiru Balasubramaniam
• [Ip-health] IP-Watch: World Health Assembly Agrees On IP And Innovation; US Abstains   Thiru Balasubramaniam
• [Ip-health] WHA A60/64: Resolution on Public health, innovation and intellectual property   Thiru Balasubramaniam
• [Ip-health] Letter to the FT: EU in danger of breaking its promise to the poor   Thiru Balasubramaniam
• [Ip-health] Financial Times: Officials fail to agree on flu virus sharing   Thiru Balasubramaniam
• [Ip-health] D Ravi Kanth's Geneva Newsletter: Bending Big (on World Health Assembly)   Thiru Balasubramaniam
• [Ip-health] New York Times: Bush Requests $30 Billion to Fight AIDS   Thiru Balasubramaniam
• [Ip-health] drug naming/patents/exclusivity   Douglas Ball
• [Ip-health] FWD: [hivaidssg] G8 docs   Jean Blaylock
• Fwd: [Ip-health] FWD: [hivaidssg] G8 docs   Jean Blaylock
• [Ip-health] From Brazil's Ministry of Health   Stephanie Burgos
• [Ip-health] Brand-Name Drug Industry Alarmed At IPR Precedent Of FTA Template   Stephanie Burgos
• [Ip-health] Petition in support of the Compulsory License in Brazil   Gabriela Chaves
• [Ip-health] Coming soon: the shopping channel run by drug firms   Michelle Childs
• [Ip-health] OUP book on TRIPS   Carlos M Correa
• [Ip-health] =?iso-8859-1?Q?RE=A0=3A_=5Bi+a=5D_UK_Government_in_support_of_Thai_and_Br?= =?iso-8859-1?Q?azil_CL?=   Nicoletta Dentico
• [Ip-health] FTAs   Peter Drahos
• [Ip-health] Merck's press release   Peter Drahos
• [Ip-health] article with overview of pressure on countries to not use compulsory licensing?   Richard Elliott
• [Ip-health] Webcast R&D Treaty   Sean Flynn
• [Ip-health] NH Court constituionalizes phrma datamining   Sean Flynn
• [Ip-health] Reimportation vote today, but also later   Sean Flynn
• [Ip-health] Drug makers fear trade deal from House Dems, administration   Sean Flynn
• [Ip-health] Second Wave of AIDS drug activism   Sean Flynn
• [Ip-health] Thailand, Brazil and the need for CLs on second generation drugs   Sean Flynn
• [Ip-health] second generation link   Sean Flynn
• [Ip-health] Guardian: Clinton backs violation of Aids drug patents   Ira Glazer
• [Ip-health] Lancet Study: WHO neglects evidence when developing 'evidence-based guidelines'   Ira Glazer
• [Ip-health] Thailand-US FTA: The unstated reason for the watch list   Ira Glazer
• [Ip-health] MSF Co-founder, Bernard Kouchner, to be named French Foreign Minister   Ira Glazer
• [Ip-health] Holding Big Pharma's feet to the fire   Ira Glazer
• [Ip-health] Will the G8 Endorse Compulsory Licenses ?   Ira Glazer
• [Ip-health] Will the G8 Endorse Compulsory Licenses ?   Ira Glazer
• [Ip-health] PhRMA: "How can a chronic, slow-acting, non-contagious condition be considered a public-health crisis?"   Ira Glazer
• [Ip-health] Eppendorf & Science Prize for Neurobiology   Ira Glazer
• [Ip-health] UK initiative to drive down cost of drugs in poor countries   Ira Glazer
• [Ip-health] EUROPEAN PARLIAMENTARIANS WELCOME THE BRASIL DECISION TO ISSUE A COMPULOSRY LICENCE TO ALLOW THE PRODUCTION OF AN ANTI-AIDS DRUG (ES-EN-FR)   Alexandra HEUMBER
• [Ip-health] European Socialist Group welcomes Brazilian decision on anti-aids drug   Alexandra HEUMBER
• [Ip-health] drug naming/patents/exclusivity   Brendan Hickey
• [Ip-health] Access to Medicines scandal in the UK...   Ellen 't Hoen
• [Ip-health] MSF letter to delegations of the 60e World Health Assembly   Ellen 't Hoen
• [Ip-health] UK Government in support of Thai and Brazil CL   Ellen 't Hoen
• [Ip-health] patent litigation costs   Aidan Hollis
• [Ip-health] Health vs economic interests   Kannikar KIJTIWATCHAKUL
• [Ip-health] US action plan must be opposed, groups tell govt   Kannikar KIJTIWATCHAKUL
• [Ip-health] Thai civil society supports the health ministers of Thailand and Brazil and calls on pharmaceutical companies and lobbyists to stop abusing their power   Kannikar KIJTIWATCHAKUL
• [Ip-health] Second-line drugs only hope for many 12,000 resistant to first-line Aids drugs   Kannikar KIJTIWATCHAKUL
• [Ip-health] Thai AIDS patients suffer as drug squabble drags on / Profit of Gloom   Kannikar KIJTIWATCHAKUL
• [Ip-health] World Trade Institute Course Programme: Summer Programme 2007   Corinne Karlaganis
• [Ip-health] Export of under patent medicine by Bangladeshi pharmaceutical industries   Dr Md Sayedur Rahman Khasru
• [Ip-health] IP Management and Innovation in Health: Handbook Published   Anatole Krattiger
• [Ip-health] =?WINDOWS-1252?Q?Brazil_CL=85?=   Gaelle Krikorian
• [Ip-health] =?WINDOWS-1252?Q?Merck_is_profoundly_disappointed=85?=   Gaelle Krikorian
• [Ip-health] Microsoft's Brief on KSR vs. Teleflex   Benjamin Krohmal
• [Ip-health] Brazil rejects Merck price offer   Benjamin Krohmal
• [Ip-health] Avorn on drug research funding   Benjamin Krohmal
• [Ip-health] Thai FDA: "no more CLs"   Benjamin Krohmal
• [Ip-health] Indian generics welcome KSR decision   Benjamin Krohmal
• [Ip-health] Thai CL news update   Benjamin Krohmal
• [Ip-health] Science on Brazil & Thailand CLs   Benjamin Krohmal
• [Ip-health] Pfizer suing Korean drug makers for infringement   Benjamin Krohmal
• [Ip-health] Drug Firms Look To Limit Deal's Impact   Benjamin Krohmal
• [Ip-health] Thai Minister of Health named chair of UNAIDS board   Benjamin Krohmal
• [Ip-health] million-dollar cancer prize announced   Benjamin Krohmal
• [Ip-health] KEI Brown Bag Lunch Wed. May 30th on US Trade Agenda   Benjamin Krohmal
• [Ip-health] TOMORROW: KEI Brown Bag on US Trade Agenda   Benjamin Krohmal
• [Ip-health] "breaking" patents   GRAIN LB
• [Ip-health] AccessNews May/June   Laura.McCULLAGH@geneva.msf.org
• [Ip-health] drug naming/patents/exclusivity   Joel Lexchin
• [Ip-health] New MSF report on health worker shortages threatening scale-up of ART   Buddhima Lokuge
• [Ip-health] AP -- Lack of doctors and nurses killing AIDS patients, says MSF   Buddhima Lokuge
• [Ip-health] Interview Minister of Health of Brazil in Folha de Sao Paulo on the US Chamber of Commerce allegations.   MSF Michel Lotrowska
• [Ip-health] Brazilian speech at the 60th World Health Assembly   MSF Michel Lotrowska
• [Ip-health] Abbott recently sought compulsory license in US patent dispute   James Love
• [Ip-health] Huffington Post: U.S. Supreme Court on Patent Policy   James Packard Love
• [Ip-health] Money instead of monopolies: European Patent Forum discussion   James Packard Love
• [Ip-health] Wall Street Journal editorial: Patently Obvious   James Packard Love
• [Ip-health] Measures to Enhance Access to Medical Technologies, and New Methods of Stimulating Medical R & D   James Packard Love
• [Ip-health] KEI statement on brazil compulsory license on efavirenz   James Packard Love
• [Ip-health] Brazil puts patients before patents, rejects Bush administration pressure and issues compulsory license on important AIDS drug   James Packard Love
• [Ip-health] Views on Brazil CL   James Packard Love
• [Ip-health] the 2005 Italian CL to export the antibiotic Imipenem Cilastatina   James Packard Love
• [Ip-health] Spicy IP: Delhi High Court on Preliminary injunctions and the presumption of validity of a 'new' patent   James Packard Love
• [Ip-health] KEI Statement on IPR/Health aspects of bipartisan "New Trade Policy"   James Packard Love
• [Ip-health] "breaking" patents   James Packard Love
• [Ip-health] Harvard Economist calls for Prizes to stimulate energy-efficient innovation   James Packard Love
• [Ip-health] Peter Pitts doesn't like KSR decision or medical innovation prizes   James Packard Love
• [Ip-health] Gotham prize to encourage openness and collaboration in cancer research   James Packard Love
• [Ip-health] Compulsory licence debate comes to the Philippines   James Packard Love
• [Ip-health] Germany: Stem cell patent partially revoked   James Packard Love
• [Ip-health] New Zealand: Drug dosage regimes now patentable   James Packard Love
• [Ip-health] Innovation prize for antimicrobial coating for medical devices   James Packard Love
• [Ip-health] Re: [thaifta] Bangkok Post, Thailand considers revoking C.L. on Merck's efavirenz   James Packard Love
• [Ip-health] THAILAND MINISTER CONSIDERING MORE COMPULSORY LICENSES   James Packard Love
• [Ip-health] The Mprize   James Packard Love
• [Ip-health] Harvard Graduate Holds X-PRIZE for ALS Research   James Packard Love
• [Ip-health] Prize4Life   James Packard Love
• [Ip-health] A B-school graduate turns his disease into a business plan -- one that he hopes could literally save his life   James Packard Love
• [Ip-health] Some recent KEI blog entries on innovation prizes   James Packard Love
• [Ip-health] Lilly money follows power shift to Dems   James Packard Love
• [Ip-health] The Mandatory CL under Article 37 of the TRIPS   James Packard Love
• [Ip-health] Bob Zoellick and medicine patents in poor countries: The Huffington Post   James Packard Love
• [Ip-health] nytimes: BMS will plead guilty to false statements re: Plavix generic competitor   Peter Maybarduk
• [Ip-health] MSF statement for the NGO-Merkel-Meeting on the G8   Oliver Moldenhauer
• [Ip-health] MSF statement for the NGO-Merkel-Meeting on the G8   Oliver Moldenhauer
• [Ip-health] Brazil's CL for Efavirenz   Pedro Moniz
• [Ip-health] drug naming/patents/exclusivity   Kirsten Myhr
• [Ip-health] June 7: Hearing on KORUS FTA at US International Trade Commission   Mike Palmedo
• [Ip-health] Outrage grows at US trade pressure - HIV groups to march on embassy; lobbyist linked to Thaksin PR firm   Mike Palmedo
• [Ip-health] The Hill: Drug Makers Fear Trade Deal from House Dems, Administration   Mike Palmedo
• [Ip-health] The Hill on Sanders Bill on Drugs Developed with Taxpayer Money   Mike Palmedo
• [Ip-health] NYT op-ed on Patents for Yoga and Patents for Drugs in India   Mike Palmedo
• [Ip-health] Q&A from Clinton Foundation. Excerpt on patents on second line ARVs   Mike Palmedo
• [Ip-health] Bloomberg: Drug firms against trade changes   Mike Palmedo
• [Ip-health] USA for Innovation letter to Congress   Mike Palmedo
• [Ip-health] Economist on Brazilian Compulsory License   Mike Palmedo
• [Ip-health] Bloomberg on Generics and the Trade Deal   Mike Palmedo
• [Ip-health] Voice of America - Cancer Rates Rising in Africa   Mike Palmedo
• [Ip-health] CQ Weekly - The Shadowy Drug Lobby That Has Thailand In Its Sites   Mike Palmedo
• [Ip-health] Bangkok Post interview with US Ambassador to Thailand   Mike Palmedo
• [Ip-health] Forum: Is Compulsory Licensing the Solution to Patients' Access to Treatment?   Mike Palmedo
• [Ip-health] Yonhap News: S. Korea, U.S. May Release Full Text of FTA on Friday, Official Says   Mike Palmedo
• [Ip-health] UPI - Is PhRMA swimming against IP tide?   Mike Palmedo
• [Ip-health] Letter from 12 House Members to USTR Asking for Release of KORUS FTA Text   Mike Palmedo
• [Ip-health] Text of the KORUS FTA   Mike Palmedo
• [Ip-health] PIJIP Comments on the Korus FTA Pharmaceuticals and IP Chapters   Mike Palmedo
• [Ip-health] Reuters: Thailand to Override More Patented Drugs, Says Minister   Mike Palmedo
• [Ip-health] Medical News Today on meetings between Thai and US govt officials   Mike Palmedo
• [Ip-health] Indian pharma firms corner chunk of US drug approvals   Prabhu Ram
• [Ip-health] Pfizer Foundation Awards $7.5 Million to Community-Based AIDS Service Organizations   Joana Ramos
• [Ip-health] UK leads initiative to drive down cost of drugs in poor countries   Joana Ramos
• [Ip-health] Norway asks Novartis to withdraw case   Joana Ramos
• [Ip-health] NPPA gets upper hand in trade margin tussle with Novartis   Joana Ramos
• [Ip-health] Fwd: Auxiliary Invitation: Cancer in Developing Countries- May 29 in DC   Joana Ramos
• [Ip-health] State of the Clinical Trials Industry 2007 Sourcebook   Joana Ramos
• [Ip-health] Novartis Will Wait Until Indian Court Issues Decision In Patents Act Challenge Before Deciding How To Proceed   Joana Ramos
• [Ip-health] Big Pay Deals Irk a CEO: One Swiss Executive,Wants National Vote,To Force Tighter Rules   Joana Ramos
• [Ip-health] UN picks Novartis boss to combat bio-terrorism   Joana Ramos
• [Ip-health] Court Ruling Could Have Chilling Effect On Organ Donations   Joana Ramos
• [Ip-health] A Genetic Test for the Dogs   Joana Ramos
• [Ip-health] Petition in support of the Compulsory License - Brazil   Renata Reis
• [Ip-health] drug naming/patents/exclusivity   Sue Rochman
• [Ip-health] Reaction of AIDS groups, public health organizations to trade policy announcement   Asia Russell
• [Ip-health] Watch Brazilian CL signature LIVE in 2 minutes   Judit Rius Sanjuan
• [Ip-health] Merck Press Release on Brazil CL   Judit Rius Sanjuan
• [Ip-health] Statement from Brazilian Civil Society   Judit Rius Sanjuan
• [Ip-health] Bridges: White House & Democrats deal on FTAs   Judit Rius Sanjuan
• [Ip-health] Bridges: WHO Members Adopt Resolution On Pharmaceutical Innovation   Judit Rius Sanjuan
• [Ip-health] Huffington Post: The Politics of Intellectual Property Rights and Access to Medicines   Judit Rius Sanjuan
• [Ip-health] Important US Supreme Court decision on obviousness (inventive step)   Josh Sarnoff
• [Ip-health] RE: [A2k] Microsoft's Brief on KSR vs. Teleflex   Josh Sarnoff
• [Ip-health] New York Times column: Doctors, Drugs and the Poor   Ann-Marie Sevcsik
• [Ip-health] FW: Dear Colleague; Trade; Health; Public Health Issues in Trade Agreements   Ellen Shaffer
• [Ip-health] WSJ: trade deal a small step for generics   Ellen Shaffer
• [Ip-health] Korea agreement: CPATH public health report card   Ellen Shaffer
• [Ip-health] Boston Globe: Biotech -- Not Just For the Rich   Michael Steffen
• [Ip-health] Job Opening: UAEM Executive Director   Robynn Sturm
• [Ip-health] Re: [Commons-Law] Post grant oppostion against Pegays filed   Dhritabrata BHATTACHARJYA Tato
• [Ip-health] FW: La France soutient la licence obligatoire sur le m=?ISO-8859-1?B?6Q==?=dicament anti-sida efavirenz   Khalil Elouardighi - Act Up-Paris
• [Ip-health] Sign-on to expand WHO Essential Medicines List for products that are cost effective "if available at generic prices"   Aelaf Worku
• [Ip-health] Sign-on to expand WHO Essential Medicines List for products that are cost effective "if available at generic prices"   Aelaf Worku
• [Ip-health] NYTimes.com: Senate Votes to Give F.D.A. Sweeping New Powers   aelaf@hotmail.com
• [Ip-health] Clinical trials as public goods   ben.krohmal@keionline.org
• [Ip-health] Bush, Congress Agree On Trade Standards   ben.krohmal@keionline.org
• [Ip-health] Pro-CL OpEd in Herald Tribune   ben.krohmal@keionline.org
• [Ip-health] Email alert: May issue of the WHO Bulletin   bulletin
• [Ip-health] e-drug's discussion of "Expanding the WHO Model Essential Medicines List"   james.love@keionline.org
• [Ip-health] 'breaking' patents   michael.davis@law.csuohio.edu
• [Ip-health] Official Launch of EU-Korea FTA   heeseob nam
• [Ip-health] Patent Linkage in KORUS FTA and Its Comparison with AUS FTA   heeseob nam
• [Ip-health] Post grant oppostion against Pegays filed   chan park
• [Ip-health] drug naming/patents/exclusivity   joan rovira
• [Ip-health] Thailand: Will Not Back Down in Face of US Threats   robert weissman
• [Ip-health] Brazil Decides to Held Hostage No More   robert weissman
• [Ip-health] US Chamber: Brazil Takes Major Step Backward on Intellectual Property Rights   robert weissman
• [Ip-health] Ken Adelman's (New) Lies   robert weissman
• [Ip-health] Patent Barriers and the Clinton Foundation announcement   robert weissman
• [Ip-health] Clinton endorses Thai, Brazil compulsory licenses   robert weissman
• [Ip-health] Embarrassing: Ken Adelman and USA for Innovation's Latest Untruths   robert weissman
• [Ip-health] Thai GPO May Sue USA for Innovation   robert weissman
• [Ip-health] US compulsory license: ring tones   robert weissman
• [Ip-health] Soaring Drug Expenditures in Canada, 1985 to 2006   robert weissman
• [Ip-health] US Senate language critical of compulsory licensing   robert weissman
• [Ip-health] PhRMA's Billy Tauzin on Thailand CLs and other issues   robert weissman
• [Ip-health] Abbott Fund Increases Commitment to Fight Against HIV/AIDS in Tanzania, Opening Country's First Corporate Foundation Office]   robert weissman
• [Ip-health] OSI Access to Essential Medicines Grant Competition   robert weissman

Last message date: Thu May 31 04:25:27 2007
Archived on: Thu May 31 03:25:29 2007

• Messages sorted by: [ thread ] [ subject ] [ date ]
• More info on this list...